http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3639268

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 68
issn 1173-8804
1179-190X
issueIdentifier 1
pageRange 66-68
publicationName BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
startingPage 66
bibliographicCitation Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59. BioDrugs. 2003;17(1):66–8. doi: 10.2165/00063030-200317010-00006. PMID: 12534321.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09674209e11499b5f89e624a13e843a6
date 200301
identifier https://doi.org/10.2165/00063030-200317010-00006
https://pubmed.ncbi.nlm.nih.gov/12534321
isPartOf https://portal.issn.org/resource/ISSN/1173-8804
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22420
https://portal.issn.org/resource/ISSN/1179-190X
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59
discusses http://id.nlm.nih.gov/mesh/M0011171
http://id.nlm.nih.gov/mesh/M0426831
http://id.nlm.nih.gov/mesh/M0006644
http://id.nlm.nih.gov/mesh/M0005349
http://id.nlm.nih.gov/mesh/M0001329
http://id.nlm.nih.gov/mesh/M0017972
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159599
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9038
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7064
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7874

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127836138

Total number of triples: 38.